Brief: Grand Pharmaceutical Sees Consol Net Profit Attributable Decrease For Six Months
05/08/2022 11:32
Aug 5 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK :
* SEES CONSOLIDATED NET PROFIT ATTRIBUTABLE RECORDED
DECREASE OF
35%-45% FOR SIX MONTHS
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement